GABA Schweiz AG
- Sector unverified
- Rank 193 / 334
GABA Schweiz AG is recorded by Swissmedic as the authorisation holder for 5 human medicines, which places it 193 of 334 authorisation holders. Its portfolio is mostly in the Synthetika category (100 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.
Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.
Key facts
| Sector | Not available |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 5 |
| Founded | Not available |
| Employees | Not available |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
GABA Schweiz AG is recorded by Swissmedic as the authorisation holder for 5 human medicines. The table shows 5 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
5 of 5 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Duraphat | 55862 | B | A01AA01 | 2003-07-31 |
| Duraphat Fluorid 5 mg/g | 56696 | B | A01AA01 | 2005-11-10 |
| Elmex fluid | 26924 | B | A01AA30 | 1962-03-02 |
| Elmex gelée | 34916 | D | A01AA51 | 1969-06-17 |
| Meridol perio Chlorhexidin Lösung 0.2% | 57479 | D | A01AB03 | 2006-07-07 |
Frequently asked questions
How many medicines does GABA Schweiz AG have authorised in Switzerland?
GABA Schweiz AG is recorded by Swissmedic as the authorisation holder for 5 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is GABA Schweiz AG based?
We have no confirmed Swiss address for GABA Schweiz AG. We add it as soon as the commercial register or the company confirms it.
Is GABA Schweiz AG a Swissmedic authorisation holder?
Yes. GABA Schweiz AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.